Tag Archives: ATTBF

Emerald Health Northern Vine Labs

Emerald Health Therapeutics to Acquire Control of Licensed Dealer Northern Vine

Emerald Health Therapeutics to Acquire Control of Licensed Dealer Northern Vine

VICTORIA, British Columbia, Oct. 26, 2017 /Weed Wire/ – Emerald Health Therapeutics Inc. (“Emerald”) (EMH.V) (EMHTF) announced today that it has signed a definitive agreement (the “Agreement”) with Northern Vine Canada Inc. (“Northern Vine”) and Abattis Bioceuticals Corp. (“Abattis”) (CSE:ATT) (ATTBF) to invest $2.5 million into Northern Vine to acquire 53% of the company and appoint three of its four directors. Abattis will continue to hold the remaining 47% of Northern Vine.

abattis bioceuticals_added_to_marijuana_index

Abattis Bioceuticals Gets Added to the Marijuana Index by MJIC

VANCOUVER, British Columbia, April 7, 2017 /Weed Wire/ — Abattis Bioceuticals Corp. (ATTBF) (CSE:ATT) (the “Company” or “Abattis”), is pleased to announce it has officially been added to The Marijuana Index, within the Biotechnology sector.

abattis

Abattis Announces the Appointment of Dr. Shuang Xie as a Director and Provides Progress Report on Initiatives in China

VANCOUVER, British Columbia, Nov. 14, 2016 /Weed Wire/ — Abattis Bioceuticals Corp. (OTCQB: ATTBF) (CSE: ATT) (the “Company” or “Abattis”), is pleased to announce the appointment of Dr. Shuang Xie to the Board of Directors. Dr. Xie recently joined Abattis as the Chief Technology Advisor and continues in that capacity.


Top